VH4524184 is named as an intervention in 2 current clinical trials in our USA register. 2 are recruiting patients now. The most common phase is Phase 1. The lead sponsor is ViiV Healthcare. The most-studied condition is HIV Infections.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT07202546 · ClinicalTrials.gov ↗ · HIV Infections
|
Phase 2 | Recruiting | ViiV Healthcare | USA |
|
First Time in Human Study of Long Acting VH4524184 Formulations
NCT06310551 · HIV Infections
|
Phase 1 | Recruiting | ViiV Healthcare | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| ViiV Healthcare | 2 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 2 | 2 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our USA register name VH4524184 as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 2 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is ViiV Healthcare. The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how VH4524184 works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how VH4524184 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists VH4524184 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.